Replimune Group, Inc.

Nasdaq:REPL

Biological Products, (No Diagnostic Substances)·WOBURN, MA

CEO

Patel Sushil

CFO

Hill Emily Luisa

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q4 2025	12/31/25	2/3/26	→
10-Q	Q3 2025	9/30/25	11/6/25	→
10-Q	Q2 2025	6/30/25	8/7/25	→
10-K	FY 2025	3/31/25	5/22/25	→
10-Q	Q4 2024	12/31/24	2/12/25	→
10-Q	Q3 2024	9/30/24	11/12/24	→
↓

Earnings Releases (8-K)

24 shown

Filed	Period
2/3/26	Q4 FY2026	→
11/6/25	Q3 FY2026	→
8/7/25	Q2 FY2026	→
5/22/25	Q1 FY2026	→
2/12/25	Q4 FY2025	→
11/12/24	Q3 FY2025	→
↓

News (8-K)

56 shown

Filed	Type	Description
1/12/26	Reg FD	Regulation FD Disclosure	→
10/20/25	Other	Other Events	→
9/18/25	Reg FD	Regulation FD Disclosure	→
9/4/25	Reg FD	Submission of Matters to a Vote of Security Holders	→
7/22/25	Reg FD	Regulation FD Disclosure	→
6/24/25	Reg FD	Regulation FD Disclosure	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
11/6/25	S-3/A	S-3/A	→
7/25/25	ARS	ARS	→
5/23/25	S-3	S-3	→
5/23/25	S-3	S-3	→
5/23/25	S-8	S-8	→
4/25/25	S-8	S-8	→
↓

Filing History(588 filings)

TypeDateAccessionPeriodSize

Feb 20, 2026

0001104659-26-018159OWNERSHIP DOCUMENT

Feb 18, 2026

4.4 KB

SCHEDULE 13G/A

Feb 17, 2026

0001193125-26-053163

—

8.9 KB

10-Q

Feb 3, 2026

0001628280-26-00480510-Q

Dec 31, 2025

8.5 MB

8-K

Feb 3, 2026

0001104659-26-009510FORM 8-K

Feb 3, 2026

255.9 KB

8-K

Jan 12, 2026

0001104659-26-002721FORM 8-K

Jan 12, 2026

5.1 MB

Dec 19, 2025

0001104659-25-123290OWNERSHIP DOCUMENT

Dec 19, 2025

5.0 KB

Dec 19, 2025

0001104659-25-123286OWNERSHIP DOCUMENT

Dec 19, 2025

5.0 KB

Dec 19, 2025

0001104659-25-123285OWNERSHIP DOCUMENT

Dec 19, 2025

5.0 KB

Dec 19, 2025

0001104659-25-123282OWNERSHIP DOCUMENT

Dec 19, 2025

5.0 KB

Dec 19, 2025

0001104659-25-123279OWNERSHIP DOCUMENT

Dec 19, 2025

5.0 KB

Dec 11, 2025

0001104659-25-120332OWNERSHIP DOCUMENT

Dec 9, 2025

8.3 KB

144

Dec 9, 2025

0001968582-25-001182

—

4.1 KB

Dec 4, 2025

0001104659-25-118483OWNERSHIP DOCUMENT

Dec 2, 2025

5.6 KB

144

Dec 2, 2025

0001968582-25-001147

—

4.3 KB

Nov 19, 2025

0001104659-25-114124OWNERSHIP DOCUMENT

Nov 17, 2025

5.6 KB

Nov 19, 2025

0001104659-25-114122OWNERSHIP DOCUMENT

Nov 17, 2025

5.6 KB

SCHEDULE 13G/A

Nov 14, 2025

0001104659-25-112548

—

10.8 KB

SCHEDULE 13G/A

Nov 14, 2025

0000902664-25-005014

—

11.8 KB

SCHEDULE 13G/A

Nov 14, 2025

0000080255-25-000829

—

7.3 KB

SCHEDULE 13G

Nov 14, 2025

0001493215-25-000047

—

12.1 KB

S-3/A

Nov 6, 2025

0001104659-25-107762S-3/A

—

734.2 KB

8-K

Nov 6, 2025

0001104659-25-107438FORM 8-K

Nov 6, 2025

255.5 KB

10-Q

Nov 6, 2025

0001628280-25-04988410-Q

Sep 30, 2025

7.3 MB

8-K

Oct 20, 2025

0001104659-25-100605FORM 8-K

Oct 20, 2025

199.9 KB

8-K

Sep 18, 2025

0001104659-25-091066FORM 8-K

Sep 16, 2025

201.0 KB

25 filings shown

Filed	Form	Description
7/25/25	DEFA14A	DEFA14A	→
7/25/25	DEF 14A	DEF 14A	→
7/19/24	DEFA14A	DEFA14A	→
7/19/24	DEF 14A	DEF 14A	→
7/26/23	DEFA14A	DEFA14A	→
7/26/23	DEF 14A	DEF 14A	→
↓

Replimune Group, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(588 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
2/20/26	4	OWNERSHIP DOCUMENT	→
12/19/25	4	OWNERSHIP DOCUMENT	→
12/19/25	4	OWNERSHIP DOCUMENT	→
12/19/25	4	OWNERSHIP DOCUMENT	→
12/19/25	4	OWNERSHIP DOCUMENT	→
12/19/25	4	OWNERSHIP DOCUMENT	→
↓

Filed	Form	Description
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
12/9/25	144	144	→
12/2/25	144	144	→
11/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
11/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
11/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
↓